G-308A TNF-α polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: Case-control study

Cancer Epidemiology

Volumn 33, Issue 3-4, 2009, Pages 261-264

  Akkiz, Hikmet ^a   Bayram, Süleyman ^a   Bekar, Aynur ^a   Özdil, Burhan ^a   Akgöllü, Ersin ^a   Sümbül, Ahmet Taner ^a   Demiryürek, Haluk ^a   Doran, Figen ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Cytokine; G 308A promoter polymorphism; Hardy Weinberg equilibrium; HBV; HCV; Hepatocellular carcinoma; PCR RFLP assay; Single nucleotide polymorphism; Susceptibility; Tumor necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALCOHOL CONSUMPTION; ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING; TURKEY (REPUBLIC);

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK; TUMOR NECROSIS FACTOR-ALPHA; TURKEY; YOUNG ADULT;

EID: 70349728447     PISSN: 18777821     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canep.2009.06.001     Document Type: Article

References (38)

1. Farazi P.A., and DePinho R.A. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 6 (2006) 674-687
2. Michielsen P.P., Francque S.M., and van Dongen J.L. Viral hepatitis and hepatocellular carcinoma. World J Surg Oncol 3 (2005) 27
3. Llovet J.M., Burroughs A., and Bruix J. Hepatocellular carcinoma. Lancet 362 (2003) 1907-1917
4. Thorgeirsson S.S., and Grisham J.W. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31 (2002) 339-346
5. Vogel A., Kneip S., Barut A., Ehmer U., Tukey R.H., Manns M.P., et al. Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene. Gastroenterology 121 (2001) 1136-1144
6. Wang Y., Kato N., Hoshida Y., Yoshida H., Taniguchi H., Goto T., et al. Interleukin-1β gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection. Hepatology 37 (2003) 65-71
7. Shin H.D., Park B.L., Kim L.H., Jung J.H., Kim J.Y., Yoon J.H., et al. Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma. Hum Mol Genet 12 (2003) 901-906
8. Wang Y., Kato N., Hoshida Y., Otsuka M., Taniguchi H., Moriyama M., et al. UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma in Japanese patients with hepatitis C virus infection. Clin Cancer Res 10 (2004) 2441-2446
9. Wild C.P., Law G.R., and Roman E. Molecular epidemiology and cancer: promising areas for future research in the post-genomic era. Mutat Res 499 (2002) 3-12
10. Anderson G.M., Nakada M.T., and DeWitte M. Tumor necrosis factor-alpha in the pathogenesis and treatment of cancer. Curr Opin Pharmacol 4 (2004) 314-320
11. Hajeer A.H., and Hutchinson I.V. TNF-α gene polymorphism: Clinical and biological implications. Microsc Res Technol 50 (2000) 216-228
12. Hajeer A.H., and Hutchinson I.V. Influence of TNFalpha gene polymorphisms on TNFalpha production and disease. Hum Immunol 62 (2001) 1191-1199
13. Wilson A.G., di Giovine F.S., Blakemore A.I., and Duff G.W. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet 1 (1992) 353
14. Mestiri S., Bouaouina N., Ahmed S.B., Khedhaier A., Jrad B.B., Remadi S., et al. Genetic variation in the tumor necrosis factor-a promoter region and in the stress protein hsp70-2: susceptibility and prognostic implications in breast carcinoma. Cancer 91 (2001) 672-678
15. Warzocha K., Ribeiro P., Bienvenu J., Roy P., Charlot C., Rigal D., et al. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome. Blood 91 (1998) 3574-3581
16. Oh B.R., Sasaki M., Perinchery G., Ryu S.B., Park Y.I., Carroll P., et al. Frequent genotype changes at -308, and 488 regions of the tumor necrosis factor-α (TNF-α) gene in patients with prostate cancer. J Urol 163 (2000) 1584-1587
17. Sasaki M., Nakajima K., Perinchery G., Fujino T., Oh B.R., Fujimoto S., et al. Frequent genotype changes at -308 of the human tumor necrosis factor-alpha promoter region in human uterine endometrial cancer. Oncol Rep 7 (2000) 369-373
18. Machado J.C., Figueiredo C., Canedo P., Pharoah P., Carvalho R., Nabais S., et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 125 2 (2003) 364-371
19. Ho S.H., Wang Y.J., Chen H.L., Chen C.H., Chang C.J., and Wang P.J. Increased risk of developing hepatocellular carcinoma associated with carriage of the TNF2 allele of the -308 tumor necrosis factor-alpha promoter gene. Cancer Causes Control 15 (2004) 657-663
20. Jeng J.E., Tsai J.F., Chuang L.Y., Ho M.S., Lin Z.Y., Hsieh M.Y., et al. Tumor necrosis factor-alpha 308 2 polymorphism is associated with advanced hepatic fibrosis and higher risk for hepatocellular carcinoma. Neoplasia 9 (2007) 987-992
21. Wu H.C., Chang C.H., Chen H.Y., Tsai F.J., Tsai J.J., and Chen W.C. p53 gene codon 72 polymorphism but not tumor necrosis factor-alpha gene is associated with prostate cancer. Urol Int 73 (2004) 41-46
22. Azmy I.A., Balasubramanian S.P., Wilson A.G., Stephenson T.J., Cox A., Brown N.J., et al. Role of tumour necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severity. Breast Cancer Res 6 (2004) R395-400
23. Ho S.Y., Wang Y.Y., Huang P.C., Tsai F.J., Tsai J.J., Chen W.C., et al. Evaluation of the associations between the single nucleotide polymorphisms of the promoter region of the tumor necrosis factor-α gene and nasopharyngeal carcinoma. J Chin Med Assoc 69 (2006) 351-357
24. Tsai J.F., Chang W.Y., Jeng J.E., Ho M.S., Lin Z.Y., and Tsai J.H. Hepatitis B and C virus infection as risk factors for liver cirrhosis and cirrhotic hepatocellular carcinoma: a case-control study. Liver 14 (1994) 98-102
25. Pugh R.N., Murray-Lyon I.M., Dawson J.L., Peitroni M.C., and Williams R. Transection of the esophagus for bleeding esophageal varices. Br J Surg 60 (1973) 646-649
26. Szlosarek P.W., and Balkwill F.R. Tumor necrosis factor alpha: a potential target for the therapy of solid tumors. Lancet Oncol 4 (2003) 565-573
27. Abraham L.J., and Kroeger K.M. Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol 66 (1999) 562-566
28. Isigkeit A.R., Hasselbach E., Ocklitz E., Brückner S., Ros A., and Gehring H. Inter-individual differences in cytokine release in patients undergoing cardiac surgery with cardiopulmonary bypass. Clin Exp Immunol 125 (2001) 80-88
29. Wang J., Pan K., Li D., and Lu D. The relationship between donor TNFalpha -308 (G/A) genotype and recipient acute GVHD in allo-BMT. Zhonghua Xue Ye Xue Za Zhi 23 (2002) 397-399
30. González S., Rodrigo L., Martíner-Borra J., López-Vázquez A., Fuentes D., Niño P., et al. TNF-α -308A promoter polymorphism is associated with enhanced TNF-α production and inflammatory activity in Crohn's patients with fistulizing disease. Am J Gastroenterol 98 (2003) 1101-1106
31. Lu H., Ouyang W., and Huang C. Inflammation, a key event in cancer development. Mol Cancer Res 4 (2006) 221-233
32. Szlosarek P., Charles K.A., and Balkwill F.R. Tumour necrosis factor-alpha as a tumour promoter. Eur J Cancer 42 (2006) 745-750
33. Balkwill F.R. TNF-alpha in promotion and progression of cancer. Cancer Metastasis Rev 25 (2006) 409-416
34. Knight B., Yeoh G.C.T., Husk K.L., Ly T., Abraham L.J., Yu C., et al. Imparied preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice. J Exp Med 192 (2000) 1809-1818
35. Brechot C. Molecular mechanisms of hepatitis B and C viruses related to liver carcinogenesis. Hepatogastroenterol 45 (1998) 1189-1196
36. Mocellin S., Rossi C.R., Pilati P., and Nitti D. Tumor necrosis factor, cancer and anticancer therapy. Cytokine Growth Factor Rev 16 (2005) 35-53
37. Leibovich S.J., Polverini P.J., Shepard H.M., Wiseman D.M., Shively V., and Nuseir N. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature 329 (1987) 630-632
38. Balasubramanian S.P., Brown N.J., and Reed M.W.R. Role of genetic polymorphisms in tumour angiogenesis. Br J Cancer 87 (2002) 1057-1065